======= GDE1 =======
== Gene Information ==
* **Official Symbol**: GDE1
* **Official Name**: glycerophosphodiester phosphodiesterase 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51573|51573]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZC3|Q9NZC3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=GDE1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GDE1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605943|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Has glycerophosphoinositol phosphodiesterase activity. Hydrolyzes lysoglycerophospholipids to produce lysophosphatidic acid (LPA) and the corresponding amines. Has little or no activity towards glycerophosphocholine. GDE1 activity can be modulated by G-protein signaling pathways (By similarity). {ECO:0000250|UniProtKB:Q9JL55, ECO:0000250|UniProtKB:Q9JL56}.
|GDPD|
|glycerophosphoinositol glycerophosphodiesterase activity|
|glycerophosphodiester phosphodiesterase activity|
|N-acylethanolamine metabolic process|
|ethanolamine-containing compound metabolic process|
|glycerophospholipid catabolic process|
|lysophospholipase activity|
|phospholipid catabolic process|
|glycerolipid catabolic process|
|cellular biogenic amine metabolic process|
|cellular amine metabolic process|
|amine metabolic process|
|primary alcohol metabolic process|
|organophosphate catabolic process|
|cytoplasmic vesicle membrane|
|cellular lipid catabolic process|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|alcohol metabolic process|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|organic hydroxy compound metabolic process|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|lipid metabolic process|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|1.71|
|[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.94|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 7315
* **Expression level (log2 read counts)**: 5.54
{{:chemogenomics:nalm6 dist.png?nolink |}}